Abrdn Life Sciences Investors (HQL)

HQL Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Apr 13, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	525	448	412	343	505	413
Market Cap Growth	-	8.58%	20.08%	-31.99%	22.27%	20.21%
Enterprise Value	527	448	412	352	505	413
Last Close Price	17.16	14.57	12.38	9.08	12.65	9.85
PE Ratio	5.93	5.23	4.84	-	7.83	3.36
PS Ratio	271.70	231.02	103.63	113.77	220.89	121.78
PB Ratio	0.99	0.87	0.90	0.86	0.97	0.85
P/TBV Ratio	1.03	0.87	0.90	0.86	0.97	0.85
P/OCF Ratio	16.61	14.12	-	-	-	-
EV/Sales Ratio	271.66	231.02	103.63	116.55	220.89	121.78
Debt / Equity Ratio	-	-	-	0.03	0.02	0
Net Debt / Equity Ratio	0	0	0	0.03	0.02	0
Asset Turnover	0.00	0.00	0.01	0.01	0.00	0.01
Quick Ratio	0.71	0.71	0.27	0.04	0.01	0.28
Current Ratio	0.73	0.73	0.32	0.70	0.80	8.88
Return on Equity (ROE)	17.59%	17.59%	19.80%	-22.71%	12.82%	28.38%
Return on Assets (ROA)	-0.43%	-0.43%	-0.28%	-0.39%	-0.51%	-0.30%
Return on Capital Employed (ROCE)	-0.70%	-0.70%	-0.40%	-0.80%	-0.80%	-0.40%
Earnings Yield	16.25%	19.11%	20.68%	-30.45%	12.78%	29.79%
Dividend Yield	10.54%	12.50%	13.41%	16.19%	13.20%	14.93%
Payout Ratio	66.05%	36.96%	-	-	-	-
Buyback Yield / Dilution	-5.48%	-5.48%	-9.28%	-4.10%	-3.29%	-3.03%
Total Shareholder Return	5.13%	7.02%	4.13%	12.09%	9.91%	11.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q